Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BMS-582949 vs Atorvastatin in Atherosclerosis
NCT00570752Phase 2Completed
- Sponsor
- Bristol Myers Squibb
- Start
- Dec 2008
- Primary completion
- Nov 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of BMS-582949 in atherosclerosis, sponsored by Bristol Myers Squibb. Started Dec 2008; status: completed.
02
Drugs
BMS-582949
03
Conditions
atherosclerosis
Beyond the preview
Go deeper on NCT00570752.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00570752.